Chinese English Germany Japanese

Shanghai Aladdin Biochemical Technology Co.,Ltd.회사는 제품 목록을 제공합니다.

회사 명:Shanghai Aladdin Biochemical Technology Co.,Ltd.
전화:400-6206333
이메일:anhua.mao@aladdin-e.com
국적:China
URL: www.aladdin-e.com/
총 제품 수:48457
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

제품 카탈로그

Meropenem-d61133424-00-6C17H25N3O5S
Imazapic이마자메트104098-48-8C14H17N3O3
IDO-IN-132291164-02-6C26H17F3N4O
Ethyl 2-oxo-4-phenylbutyrate64920-29-2C12H14O3
Dysprosium(III) trifluoromethanesulfonate139177-62-1C3DyF9O9S3
Dehydroepiandrosterone sulfate10,13-디메틸-17-옥소-3-술포옥시-1,2,3,4,7,8,9,11,12,14,15,16-도데카히드로시클로펜타[a]페난트렌651-48-9C19H28O5S
Bis(hexamethylene)triamine143-23-7C12H29N3
Benzyldiphenylphosphine7650-91-1C19H17P
Nadecnemab (anti-GFRA3)2377679-19-9
Bimagrumab (anti-ACVR2B)1356922-05-8
Xentuzumab (anti-IGF1)1417158-65-6
Telazorlimab (anti-TNFRSF4)2126777-87-3
Ranibizumab (anti-VEGFA)347396-82-1C11H12N2O2
Codrituzumab (anti-GPC3)1365267-33-9
Urelumab (anti-TNFRSF9)934823-49-1
Elotuzumab (anti-SLAMF7)915296-00-3
Alizarin Yellow R sodium salt1718-34-9C13H8N3NaO5
Apelin 17 TFAAPELIN전구체(61-77)(인간,뼈,마우스,쥐)트리플루오로아세테이트217082-57-0C96H156N34O20S
2-(azetidin-1-yl)ethan-1-amine795299-77-3C5H12N2
8-Azahypoxanthine8-아자하이폭산틴2683-90-1C4H3N5O
Rosmantuzumab (anti-RSPO3)1684393-04-1
Quetmolimab (anti-CX3CL1)2084037-83-0
Sirtratumab (anti-SLITRK6)1824663-82-2
Lumiliximab (anti-FceR2)357613-86-6
Tamrintamab (anti-DPEP3)2148325-59-9
Galiximab (anti-CD80)갈릭시맙357613-77-5
Lacnotuzumab (anti-M-CSF)1831128-32-5
Bivatuzumab (anti-CD44v6)214559-60-1
Tesidolumab (anti-Complement C5)1531594-08-7
Ravulizumab (anti-Complement C5)1803171-55-2
Itolizumab (anti-CD6)1116433-11-4
Cinpanemab (anti-Alpha-synuclein)2094516-02-4
Vopratelimab (anti-ICOS)2039148-04-2
Narsoplimab (anti-MASP2)2108782-45-0
Tesnatilimab (anti-NKG2D)2242758-08-1
Mogamulizumab (anti-CCR4)1159266-37-1
Apamistamab (anti-PTPRC)2097132-02-8
KWAR23 (anti-SIRPg)2243227-60-1
Bexmarilimab (anti-STAB1)2259301-27-2
Idactamab (anti-SLC1A5)2245205-37-0
Sonepcizumab (anti-Sphingosine-1-phosphate)1031360-18-5
Zagotenemab (anti-Tau)2019133-28-7
Tisotumab (anti-F3)1418628-81-5
Concizumab (anti-TFPI)1312299-39-0
Ladiratuzumab (anti-SLC39A6)1629760-28-6
Narnatumab (anti-RON)1188275-92-4
Vandortuzumab (anti-STEAP1)1557989-52-2
Serplulimab (anti-PDCD1)2231029-82-4
Lexatumumab (anti-TNFRSF10B)렉사투무맙845816-02-6
Ianalumab (anti-TNFRSF13C)1929549-92-7
Ragifilimab (anti-TNFRSF18)2207590-51-8
Oxelumab (anti-TNFSF4)1186098-83-8
Vorsetuzumab (anti-CD70)1165740-62-4
Flanvotumab (anti-TYRP1)1188277-05-5
Lemzoparlimab (anti-CD47)2377483-71-9
Ulocuplumab (anti-CXCR4)1375830-34-4
Indusatumab (anti-GUCY2C)1497400-26-6
Ixekizumab (anti-CTLA-8)1143503-69-8N/A
Gemtuzumab (anti-CD33)젬투주맙220578-59-6
Gevokizumab (anti-IL-1b)면역글로불린G21129435-60-4
Fulranumab (anti-NGF)902141-80-4
Guselkumab (anti-IL-23)1350289-85-8
Zansecimab (anti-ANGPT2)2415205-37-5
Vunakizumab (anti-IL-17a)1792181-33-9
Vantictumab (anti-FZD)1345009-45-1
Tarextumab (anti-NOTCH3)1359940-55-8
Sirukumab (anti-IL-6)1194585-53-9
Seribantumab (anti-ERBB3)1334296-12-6
Pascolizumab (anti-IL-4)331243-22-2
Otilimab (anti-GM-CSF)1638332-55-4
Ontamalimab (anti-MADCAM1)2098790-40-8
Ocrelizumab (anti-CD20)637334-45-3C19H16N2O5
Labetuzumab govitecan (anti-CEACAM5)1469876-18-3
Imaprelimab (anti-CD146)2014343-04-3
Enokizumab (anti-IL-9)909875-08-7
Enoblituzumab (anti-CD276)1353485-38-7
Dostarlimab (anti-PD-1)2022215-59-2
Dinutuximab (anti-GD2)1363687-32-4
Depatuxizumab mafodotin (anti-EGFR)1585973-65-4
Carotuximab (anti-CD105)1268714-50-6
Brazikumab (anti-IL-23)1610353-18-8
Bermekimab (anti-IL-1a)1401965-15-8
Avdoralimab (anti-C5AR1)2226393-85-5
Abelacimab(anti-Factor XI)2098724-83-3
Ponsegromab (anti-GDF15)2368950-15-4
Prezalumab (anti-B7-H2)1523164-68-2
Rilotumumab (anti-HGF)872514-65-3
Tinurilimab (anti-CEACAM6)2226224-30-0
Belimumab (anti-TNFSF13B)벨리무맙356547-88-1
Girentuximab (anti-CA9)916138-87-9
Daclizumab (anti-IL2RA)다클리시맙152923-56-3
Datopotamab (anti-TROP2)2267989-53-5
Daxdilimab (anti-ILT7)2245966-28-1
Efalizumab (anti-ITGAL)에팔리주마붐214745-43-4
Eldelumab (anti-CXCL10)946414-98-8
Emibetuzumab (anti-MET)1365287-97-3
Enfortumab (anti-NECTIN4)1448664-46-7
Eculizumab (anti-Complement C5)219685-50-4
Inebilizumab (anti-CD19)1299440-37-1
Denintuzumab (anti-CD19)1630074-14-4
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 © ChemicalBook. All rights reserved